Status:
UNKNOWN
Prospective Cohort Study of Disease and Outcomes in Cirrhosis
Lead Sponsor:
Copenhagen University Hospital, Hvidovre
Collaborating Sponsors:
University of Copenhagen
Conditions:
Liver Cirrhosis, Alcoholic
Progression
Eligibility:
All Genders
18+ years
Brief Summary
A population based incidence cohort will enroll patients newly diagnosed with cirrhosis to investigate disease characteristics and outcomes, explore mechanisms predicting early death and hospital admi...
Detailed Description
INTRODUCTION In Denmark the incidence of liver cirrhosis is increasing. From 1996 to 2005 the number of hospital admissions due to liver cirrhosis rose with 2,500 extra admissions per year. Patients w...
Eligibility Criteria
Inclusion
- Clinical suspicion of cirrhosis supported by biochemistry and ultrasound or other imaging techniques.
- Cirrhosis of any etiology
- Informed written consent
Exclusion
- People where the diagnosis of liver cirrhosis is questioned with reasonable doubt or the diagnosis of liver cirrhosis is disproved by histology or relevant imaging.
- Withdrawal of informed consent or no informed consent.
- Persons eligible for inclusion where the investigational program is delayed or not initiated within six months after the diagnosis of suspected cirrhosis.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT04422223
Start Date
November 1 2019
End Date
December 30 2024
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nina Kimer
Hvidovre, Please Enter the State Or Province, Denmark, 2650